BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21349181)

  • 1. The creation of the health consumer: challenges on health sector regulation after managed care era.
    Iriart C; Franco T; Merhy EE
    Global Health; 2011 Feb; 7():2. PubMed ID: 21349181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Financial capital versus medical-industrial complex: challenges for the regulatory agencies].
    Iriart C
    Cien Saude Colet; 2008; 13(5):1619-26. PubMed ID: 18813662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public sector reforms and their impact on the level of corruption: A systematic review.
    Mugellini G; Della Bella S; Colagrossi M; Isenring GL; Killias M
    Campbell Syst Rev; 2021 Jun; 17(2):e1173. PubMed ID: 37131927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing the health care market in developing countries: prospects and problems.
    Broomberg J
    Health Policy Plan; 1994 Sep; 9(3):237-51. PubMed ID: 10137740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multinational corporations and health care in the United States and Latin America: strategies, actions, and effects.
    Jasso-Aguilar R; Waitzkin H; Landwehr A
    J Health Soc Behav; 2004; 45 Suppl(Suppl):136-57. PubMed ID: 15779471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical companies and their drugs on social media: a content analysis of drug information on popular social media sites.
    Tyrawski J; DeAndrea DC
    J Med Internet Res; 2015 Jun; 17(6):e130. PubMed ID: 26032738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Greece: Health system review.
    Economou C
    Health Syst Transit; 2010; 12(7):1-177, xv-xvi. PubMed ID: 21330233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenge of healthcare big data to China's commercial health insurance industry: evaluation and recommendations.
    Wu J; Qiao J; Nicholas S; Liu Y; Maitland E
    BMC Health Serv Res; 2022 Sep; 22(1):1189. PubMed ID: 36138390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Private initiatives and policy options: recent health system experience in India.
    Purohit BC
    Health Policy Plan; 2001 Mar; 16(1):87-97. PubMed ID: 11238435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financial impact of energy efficiency and energy policies aimed at power sector reforms: mediating role of financing in the power sector.
    Liu H; Khan AR; Aslam S; Rasheed AK; Mohsin M
    Environ Sci Pollut Res Int; 2022 Mar; 29(13):18891-18904. PubMed ID: 34705201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosimilar Drugs for Multiple Sclerosis: An Unmet International Need or a Regulatory Risk?
    Rivera VM
    Neurol Ther; 2019 Dec; 8(2):177-184. PubMed ID: 31313222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical Marketing in the United States, 1997-2016.
    Schwartz LM; Woloshin S
    JAMA; 2019 Jan; 321(1):80-96. PubMed ID: 30620375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Managed care in Latin America: transnationalization of the health sector in the context of reform].
    Iriart C; Merhy EE; Waitzkin H
    Cad Saude Publica; 2000; 16(1):95-105. PubMed ID: 10738154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managed care in Latin America: the new common sense in health policy reform.
    Iriart C; Merhy EE; Waitzkin H
    Soc Sci Med; 2001 Apr; 52(8):1243-53. PubMed ID: 11281407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of insurance in the achievement of universal coverage within a developing country context: South Africa as a case study.
    van den Heever AM
    BMC Public Health; 2012; 12 Suppl 1(Suppl 1):S5. PubMed ID: 22992410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Market reforms and public incentives: finding a balance in the Republic of Macedonia.
    Nordyke RJ; Peabody JW
    Soc Sci Med; 2002 Mar; 54(6):939-53. PubMed ID: 11996027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Foreign capital and structural change in the Brazilian private health services market].
    Kamia FD; Vargas MA
    Cad Saude Publica; 2023; 39(9):e00171222. PubMed ID: 37792818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hearing focuses on price of Norplant; Wyeth pledges discount for public sector.
    Wash Memo Alan Guttmacher Inst; 1993 Nov; (18):3-4. PubMed ID: 12318533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of financial statements from companies in the Brazilian health sector (2009-2015): concentration, centralization of capital, and expressions of financialization].
    Andrietta LS; Monte-Cardoso A
    Cad Saude Publica; 2022; 38Suppl 2(Suppl 2):e00006020. PubMed ID: 36043616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.